These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 34381983)

  • 1. Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis.
    Laschtowitz A; Zachou K; Lygoura V; Pape S; Derben F; Jaeckel E; Oller-Moreno S; Weidemann S; Krech T; Piecha F; Schön G; Liebhoff AM; Al Tarrah M; Heneghan M; Drenth JPH; Dalekos G; Taubert R; Lohse AW; Schramm C
    JHEP Rep; 2021 Aug; 3(4):100321. PubMed ID: 34381983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of biochemical remission and transient elastography in monitoring disease course in autoimmune hepatitis.
    Hartl J; Ehlken H; Sebode M; Peiseler M; Krech T; Zenouzi R; von Felden J; Weiler-Normann C; Schramm C; Lohse AW
    J Hepatol; 2018 Apr; 68(4):754-763. PubMed ID: 29180000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Features and outcome of AIH patients without elevation of IgG.
    Hartl J; Miquel R; Zachou K; Wong GW; Asghar A; Pape S; Sebode M; Peiseler M; Zenouzi R; Ehlken H; Krech T; Weiler-Normann C; Drenth JPH; Oo YH; Dalekos GN; Heneghan M; Schramm C; Lohse AW
    JHEP Rep; 2020 Jun; 2(3):100094. PubMed ID: 32280942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease.
    Vesterhus M; Nielsen MJ; Hov JR; Saffioti F; Manon-Jensen T; Leeming DJ; Moum B; Boberg KM; Pinzani M; Karlsen TH; Karsdal MA; Thorburn D
    JHEP Rep; 2021 Feb; 3(1):100178. PubMed ID: 33225252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of mycophenolate mofetil
    Dalekos GN; Arvaniti P; Gatselis NK; Gabeta S; Samakidou A; Giannoulis G; Rigopoulou E; Koukoulis GK; Zachou K
    JHEP Rep; 2022 Dec; 4(12):100601. PubMed ID: 36411768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum of Autoimmune Liver Disease and Real-World Treatment Experience from a Tertiary Care Hospital.
    Taneja S; Mehtani R; De A; Mitra S; Rathi S; Verma N; Premkumar M; Minz R; Duseja A; Das A; Singh V; Dhiman RK; Chawla YK
    J Clin Exp Hepatol; 2023; 13(2):241-251. PubMed ID: 36950480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world experience with obeticholic acid in patients with primary biliary cholangitis.
    D'Amato D; De Vincentis A; Malinverno F; Viganò M; Alvaro D; Pompili M; Picciotto A; Palitti VP; Russello M; Storato S; Pigozzi MG; Calvaruso V; De Gasperi E; Lleo A; Castellaneta A; Pellicelli A; Cazzagon N; Floreani A; Muratori L; Fagiuoli S; Niro GA; Feletti V; Cozzolongo R; Terreni N; Marzioni M; Pellicano R; Pozzoni P; Baiocchi L; Chessa L; Rosina F; Bertino G; Vinci M; Morgando A; Vanni E; Scifo G; Sacco R; D'Antò M; Bellia V; Boldizzoni R; Casella S; Omazzi B; Poggi G; Cristoferi L; Gerussi A; Ronca V; Venere R; Ponziani F; Cannavò M; Mussetto A; Fontana R; Losito F; Frazzetto E; Distefano M; Colapietro F; Labanca S; Marconi G; Grassi G; Galati G; O'Donnell SE; Mancuso C; Mulinacci G; Palermo A; Claar E; Izzi A; Picardi A; Invernizzi P; Carbone M; Vespasiani-Gentilucci U;
    JHEP Rep; 2021 Apr; 3(2):100248. PubMed ID: 33681748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy.
    Verma S; Gunuwan B; Mendler M; Govindrajan S; Redeker A
    Am J Gastroenterol; 2004 Aug; 99(8):1510-6. PubMed ID: 15307869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Right and left liver lobe biopsies by minilaparoscopy reveal clinically significant sampling error in staging and grading of autoimmune hepatitis.
    Johannes H; Malte W; Shaima A; Marcial S; Sören W; Anastasiya P; Christina WN; Christoph S; Willhelm LA; Till K; Jörg S
    Liver Int; 2023 Jun; 43(6):1269-1276. PubMed ID: 37066519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of Outcomes in Autoimmune Hepatitis Presenting as Acute on Chronic Liver Failure Without Extrahepatic Organ Dysfunction upon Treatment With Steroids.
    Sharma S; Agarwal S; Gopi S; Anand A; Mohta S; Gunjan D; Yadav R; Saraya A
    J Clin Exp Hepatol; 2021; 11(2):171-180. PubMed ID: 33746441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver inflammation activity in patients with autoimmune hepatitis with normal alanine aminotransferase and immunoglobulin G levels.
    Chen Y; Liu J; Wang J; Wu W; Wang H; Liu Y; Zhang Z; Zhang S; Pan Y; Li Y; Ding W; Zhu L; Zhu C; Li J; Qiu Y; Huang R; Wu C
    J Transl Autoimmun; 2024 Jun; 8():100220. PubMed ID: 38188039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased serum DNase1-activity in patients with autoimmune liver diseases.
    Gatselis NK; Vakrakou AG; Zachou K; Androutsakos T; Azariadis K; Hatzis G; Manoussakis MN; Dalekos GN
    Autoimmunity; 2017 Mar; 50(2):125-132. PubMed ID: 28263100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Prognostic Significance of Persisting Histological Activity Despite Biochemical Remission in Autoimmune Hepatitis.
    Dhaliwal HK; Hoeroldt BS; Dube AK; McFarlane E; Underwood JC; Karajeh MA; Gleeson D
    Am J Gastroenterol; 2015 Jul; 110(7):993-9. PubMed ID: 26010310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment responses and outcomes in patients with autoimmune hepatitis and concomitant features of non-alcoholic fatty liver disease.
    Zachou K; Azariadis K; Lytvyak E; Snijders RJALM; Takahashi A; Gatselis NK; Robles M; Andrade RJ; Schramm C; Lohse AW; Tanaka A; Drenth JPH; Montano-Loza AJ; Dalekos GN;
    JHEP Rep; 2023 Aug; 5(8):100778. PubMed ID: 37456672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical features of 107 autoimmune hepatitis patients and 30 of them with AIH-primary biliary cirrhosis overlap syndrome].
    Qiu DK; Li XM; Wei J; Ye LJ; Peng YS; Ma X
    Zhonghua Gan Zang Bing Za Zhi; 2008 May; 16(5):367-71. PubMed ID: 18510851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-cell activating factor and IL-21 levels predict treatment response in autoimmune hepatitis.
    Biewenga M; Heidt S; Vergunst M; Marijnissen CMJ; de Man RA; van der Eijk AA; van der Meer AJ; Trouw LA; van Hoek B
    JHEP Rep; 2022 May; 4(5):100460. PubMed ID: 35368991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, biochemical and histological features related to treatment response and prognosis in autoimmune hepatitis.
    Guedes LR; Cançado GGL; Santos BC; Jacomassi LDS; Nardelli MJ; Osório FMF; Faria LC; Couto CA
    Ann Hepatol; 2024; 29(4):101497. PubMed ID: 38460715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute Exacerbation to Autoimmune Hepatitis Mimicking Acute Viral Hepatitis-A Case Series and Review of Literature.
    Taneja S; Kumar P; Mitra S; Duseja A; Minz R; Das A; Dhiman RK; Chawla Y
    J Clin Exp Hepatol; 2018 Mar; 8(1):98-103. PubMed ID: 29743801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Immunoglobulin G Levels Predict Biochemical and Histological Remission of Autoimmune Hepatitis Type 1: A Single-Center Experience and Literature Review.
    Li Y; Yan L; Wang R; Wang Q; You Z; Li B; Zhang J; Huang B; Chen Y; Li Y; Lian M; Tang R; Qiu D; Gershwin ME; Xiao X; Miao Q; Ma X
    Clin Rev Allergy Immunol; 2022 Apr; 62(2):292-300. PubMed ID: 33512642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Belimumab is a promising third-line treatment option for refractory autoimmune hepatitis.
    Arvaniti P; Giannoulis G; Gabeta S; Zachou K; Koukoulis GK; Dalekos GN
    JHEP Rep; 2020 Aug; 2(4):100123. PubMed ID: 32671332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.